| Two-Step Red-Mediated Recombination for versatile High-Efficiency Markerless DNA Manipulation in Escherichia Coli B Karstentischer, J von Einem, B Kaufer, N Osterrieder Biotechniques 40 (2), 191-197, 2006 | 906 | 2006 |
| En Passant Mutagenesis: A Two Step Markerless Red Recombination System BK Tischer, GA Smith, N Osterrieder In Vitro Mutagenesis Protocols: Third Edition, 421-430, 2010 | 652 | 2010 |
| Marek's disease virus: from miasma to model N Osterrieder, JP Kamil, D Schumacher, BK Tischer, S Trapp Nature Reviews Microbiology 4 (4), 283-294, 2006 | 494 | 2006 |
| Egress of alphaherpesviruses: comparative ultrastructural study H Granzow, BG Klupp, W Fuchs, J Veits, N Osterrieder, TC Mettenleiter Journal of virology 75 (8), 3675-3684, 2001 | 424 | 2001 |
| Equine herpesvirus‐1 consensus statement DP Lunn, N Davis‐Poynter, M Flaminio, DW Horohov, K Osterrieder, ... Journal of Veterinary Internal Medicine 23 (3), 450-461, 2009 | 379 | 2009 |
| A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model J Kreye, SM Reincke, HC Kornau, E Sánchez-Sendin, VM Corman, H Liu, ... Cell 183 (4), 1058-1069. e19, 2020 | 331 | 2020 |
| Delivery of foreign antigens by engineered outer membrane vesicle vaccines DJ Chen, N Osterrieder, SM Metzger, E Buckles, AM Doody, MP DeLisa, ... Proceedings of the National Academy of Sciences 107 (7), 3099-3104, 2010 | 326 | 2010 |
| The interacting UL31 and UL34 gene products of pseudorabies virus are involved in egress from the host-cell nucleus and represent components of primary enveloped but not mature … W Fuchs, BG Klupp, H Granzow, N Osterrieder, TC Mettenleiter Journal of virology 76 (1), 364-378, 2002 | 315 | 2002 |
| Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant D Schumacher, BK Tischer, W Fuchs, N Osterrieder Journal of virology 74 (23), 11088-11098, 2000 | 282 | 2000 |
| Evidence for novel hepaciviruses in rodents JF Drexler, VM Corman, MA Müller, AN Lukashev, A Gmyl, B Coutard, ... PLoS pathogens 9 (6), e1003438, 2013 | 253 | 2013 |
| A point mutation in a herpesvirus polymerase determines neuropathogenicity LB Goodman, A Loregian, GA Perkins, J Nugent, EL Buckles, B Mercorelli, ... PLoS pathogens 3 (11), e160, 2007 | 251 | 2007 |
| Virus-induced senescence is a driver and therapeutic target in COVID-19 S Lee, Y Yu, J Trimpert, F Benthani, M Mairhofer, P Richter-Pechanska, ... Nature 599 (7884), 283-289, 2021 | 240 | 2021 |
| Age-dependent progression of SARS-CoV-2 infection in Syrian hamsters N Osterrieder, LD Bertzbach, K Dietert, A Abdelgawad, D Vladimirova, ... Viruses 12 (7), 779, 2020 | 227 | 2020 |
| Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity JJ Chiang, KMJ Sparrer, M van Gent, C Lässig, T Huang, N Osterrieder, ... Nature immunology 19 (1), 53-62, 2018 | 219 | 2018 |
| SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals NC Gassen, J Papies, T Bajaj, J Emanuel, F Dethloff, RL Chua, J Trimpert, ... Nature communications 12 (1), 3818, 2021 | 206 | 2021 |
| Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth F Dorange, BK Tischer, JF Vautherot, N Osterrieder Journal of virology 76 (4), 1959-1970, 2002 | 158 | 2002 |
| Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1) LB Goodman, B Wagner, M Flaminio, KH Sussman, SM Metzger, ... Vaccine 24 (17), 3636-3645, 2006 | 157 | 2006 |
| The Protein Encoded by the US3 Orthologue of Marek's Disease Virus Is Required for Efficient De-Envelopment of Perinuclear Virions and Involved in Actin Stress … D Schumacher, BK Tischer, S Trapp, N Osterrieder Journal of virology 79 (7), 3987-3997, 2005 | 157 | 2005 |
| A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis S Trapp, MS Parcells, JP Kamil, D Schumacher, BK Tischer, PM Kumar, ... The Journal of experimental medicine 203 (5), 1307-1317, 2006 | 156 | 2006 |
| Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes L Petherbridge, AC Brown, SJ Baigent, K Howes, MA Sacco, ... Journal of virology 78 (23), 13376-13380, 2004 | 154 | 2004 |
